Estrogen-related genes and the fat mass and obesity-associated (FTO) gene play a critical role in estrogen metabolism, and those polymorphisms are associated with a poor prognosis in breast cancer. The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.